Market Cap 133.33M
Revenue (ttm) 0.00
Net Income (ttm) -24.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 878,000
Avg Vol 3,195,084
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 2%
Beta -1.10
Analysts Strong Buy
Price Target $2.00

Company Profile

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, United States
HedgeAlerts
HedgeAlerts Nov. 16 at 10:18 PM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.07 - $0.25 Exit Price Target: $0.13 Profit Margin: +84% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ForestFoxes
ForestFoxes Nov. 16 at 7:46 PM
📚9 🫆👀 Journalists, SEC, FDA, lawyers, et al. $ANVS and their CEO poaching from patients and their families to buy their stock is one of the saddest and most despicable acts that I've ever witnessed while watching"Annovis Patients' Live Forum: Your Questions Answered" earlier this year 🙂‍↕️ https://www.youtube.com/watch?v=W-qYg0AL-8s&t=3s This is from a CEO who bragged here on Stockwits "At this point our drug looks more promising than any Alzheimer drug on the market or in development" Dr. Maccecchini Mar 02, 2025 11:38 AM https://stocktwits.com/MaccM/message/606412928 IMO, nothing can be further from the truth 😵‍💫 I've connected with Dr. Maccecchini hundreds of times and seen her disregard SEC requirements, break contracts, steal employee(s), and mislead shareholders and patients alike. She tellings everyone she's amazing at designing drug studies, yet none of her studies are robust enough to ever gain approval or be contemplated for acquisition by Big Pharma as she often states to shareholders. Despite this she tell the audience, which includes patients and their loved ones, that she "900% certain her drug works!" Instead of focusing on 1st Amendment rights for CEOs, when do we focus on protecting patients??? 💔 🤨👉 Amazingly, long-term investors condone this behavior ... and some even endorse it 😨 IMO, the majority long-term investors have loss all objectivity ... and, worst have engaged in attacking others with Dr. Maccecchini's setting the example with her use of DARVO (see attached images) I apologize for "the same ole" post @Silv1234. However, it is necessary so that new visitors on this channel (which would include families seeking to invest in companies, such as $CGTX $AVXL $SAVA $BIVI helping to bring about a cure for a loved one) are aware of the many Annovis Bio red flags 🚩🚩🚩🚩🚩 One of them is the continuous rotation of CFO's. No doubt this will continue ... and, hence provide fresh content! 📚1🔍 has an exciting new PR released this morning! https://stocktwits.com/ForestFoxes/message/635186791 📚2🔍 had an exciting PR last month, too! https://stocktwits.com/ForestFoxes/message/635204457 📚3🔍 yet another exciting new PR released hours ago w/ three ✅✅✅! https://stocktwits.com/ForestFoxes/message/635309551 📚4🔍 and ... yet another exciting new PR release that's GOLD! https://stocktwits.com/ForestFoxes/message/635505201 📚5🔍 because this post crosses over AVXL+ANVS https://stocktwits.com/ForestFoxes/message/635555392 6🔍 Dr. Maccecchini ... Goes on the Attack! https://stocktwits.com/ForestFoxes/message/635556973 (cont.) #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #GoTeamFox #Parkinsons #Research #FindACure #UnityWalk #OutrunPD #NIH #NIA #SEC
4 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 16 at 3:23 PM
Enter: $SAVA Calls Strike Price: $3 Expiry Date: DEC 05 2025 Buy in Price: $0.26 - $0.40 Sell Price: $0.72 Profit : +80% (Turn every $1 into $1.80) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.07 - $0.25 Exit Price Target: $0.13 Profit Margin: +84% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Ophirnews
Ophirnews Nov. 15 at 7:47 PM
SAVA still weighed down by legal and clinical uncertainty. Alzheimer’s program stalled; volatility remains headline-driven. $SAVA
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 15 at 3:13 PM
💎 LiquidTheta® Live Actionable Trade Asset: $SAVA Contracts: $SAVA January 15, 2027 $3 Calls Scale in: $1.10- $1.34 Scale out: $4.28-$7.34 Profit Potential : 251% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Duncanidaho2605
Duncanidaho2605 Nov. 15 at 2:52 PM
$SAVA Compliance Weekly author Jocelyn Jaeger has article on Cassava re court case. Pay wall , specialty magazine. I can’t get it.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 11:13 AM
Enter: $SAVA Calls Strike Price: $3 Expiry Date: DEC 05 2025 Buy in Price: $0.26 - $0.40 Sell Price: $0.72 Profit : +80% (Turn every $1 into $1.80) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
WhosYourDaddy_
WhosYourDaddy_ Nov. 14 at 10:52 PM
$SAVA I would like to thank you, Baggies, for selling and giving me the opportunity to buy 9550 today. I will see you in 6 months or less with my payout profit. I do have a tight stop loss
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Nov. 14 at 10:03 PM
$AVXL $SAVA Indeed .
0 · Reply
Latest News on SAVA
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Oct 22, 2025, 8:00 AM EDT - 25 days ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors


Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 8 months ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data


Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 11 months ago

Cassava Sciences Provides a Business Update


HedgeAlerts
HedgeAlerts Nov. 16 at 10:18 PM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.07 - $0.25 Exit Price Target: $0.13 Profit Margin: +84% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ForestFoxes
ForestFoxes Nov. 16 at 7:46 PM
📚9 🫆👀 Journalists, SEC, FDA, lawyers, et al. $ANVS and their CEO poaching from patients and their families to buy their stock is one of the saddest and most despicable acts that I've ever witnessed while watching"Annovis Patients' Live Forum: Your Questions Answered" earlier this year 🙂‍↕️ https://www.youtube.com/watch?v=W-qYg0AL-8s&t=3s This is from a CEO who bragged here on Stockwits "At this point our drug looks more promising than any Alzheimer drug on the market or in development" Dr. Maccecchini Mar 02, 2025 11:38 AM https://stocktwits.com/MaccM/message/606412928 IMO, nothing can be further from the truth 😵‍💫 I've connected with Dr. Maccecchini hundreds of times and seen her disregard SEC requirements, break contracts, steal employee(s), and mislead shareholders and patients alike. She tellings everyone she's amazing at designing drug studies, yet none of her studies are robust enough to ever gain approval or be contemplated for acquisition by Big Pharma as she often states to shareholders. Despite this she tell the audience, which includes patients and their loved ones, that she "900% certain her drug works!" Instead of focusing on 1st Amendment rights for CEOs, when do we focus on protecting patients??? 💔 🤨👉 Amazingly, long-term investors condone this behavior ... and some even endorse it 😨 IMO, the majority long-term investors have loss all objectivity ... and, worst have engaged in attacking others with Dr. Maccecchini's setting the example with her use of DARVO (see attached images) I apologize for "the same ole" post @Silv1234. However, it is necessary so that new visitors on this channel (which would include families seeking to invest in companies, such as $CGTX $AVXL $SAVA $BIVI helping to bring about a cure for a loved one) are aware of the many Annovis Bio red flags 🚩🚩🚩🚩🚩 One of them is the continuous rotation of CFO's. No doubt this will continue ... and, hence provide fresh content! 📚1🔍 has an exciting new PR released this morning! https://stocktwits.com/ForestFoxes/message/635186791 📚2🔍 had an exciting PR last month, too! https://stocktwits.com/ForestFoxes/message/635204457 📚3🔍 yet another exciting new PR released hours ago w/ three ✅✅✅! https://stocktwits.com/ForestFoxes/message/635309551 📚4🔍 and ... yet another exciting new PR release that's GOLD! https://stocktwits.com/ForestFoxes/message/635505201 📚5🔍 because this post crosses over AVXL+ANVS https://stocktwits.com/ForestFoxes/message/635555392 6🔍 Dr. Maccecchini ... Goes on the Attack! https://stocktwits.com/ForestFoxes/message/635556973 (cont.) #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #GoTeamFox #Parkinsons #Research #FindACure #UnityWalk #OutrunPD #NIH #NIA #SEC
4 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 16 at 3:23 PM
Enter: $SAVA Calls Strike Price: $3 Expiry Date: DEC 05 2025 Buy in Price: $0.26 - $0.40 Sell Price: $0.72 Profit : +80% (Turn every $1 into $1.80) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.07 - $0.25 Exit Price Target: $0.13 Profit Margin: +84% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Ophirnews
Ophirnews Nov. 15 at 7:47 PM
SAVA still weighed down by legal and clinical uncertainty. Alzheimer’s program stalled; volatility remains headline-driven. $SAVA
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 15 at 3:13 PM
💎 LiquidTheta® Live Actionable Trade Asset: $SAVA Contracts: $SAVA January 15, 2027 $3 Calls Scale in: $1.10- $1.34 Scale out: $4.28-$7.34 Profit Potential : 251% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Duncanidaho2605
Duncanidaho2605 Nov. 15 at 2:52 PM
$SAVA Compliance Weekly author Jocelyn Jaeger has article on Cassava re court case. Pay wall , specialty magazine. I can’t get it.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 11:13 AM
Enter: $SAVA Calls Strike Price: $3 Expiry Date: DEC 05 2025 Buy in Price: $0.26 - $0.40 Sell Price: $0.72 Profit : +80% (Turn every $1 into $1.80) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
WhosYourDaddy_
WhosYourDaddy_ Nov. 14 at 10:52 PM
$SAVA I would like to thank you, Baggies, for selling and giving me the opportunity to buy 9550 today. I will see you in 6 months or less with my payout profit. I do have a tight stop loss
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Nov. 14 at 10:03 PM
$AVXL $SAVA Indeed .
0 · Reply
bigron8671
bigron8671 Nov. 14 at 6:50 PM
$SAVA Really ?
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:03 PM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.04 - $0.08 Exit Price Target: $0.07 Profit Margin: +81% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
bigron8671
bigron8671 Nov. 14 at 3:36 PM
$SAVA down
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 2:33 PM
💎 LiquidTheta® Live Actionable Trade Asset: $SAVA Contracts: $SAVA January 15, 2027 $3 Calls Scale in: $1.18- $1.44 Scale out: $4.58-$7.86 Profit Potential : 412% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Cdude1897
Cdude1897 Nov. 14 at 12:44 PM
$AVXL $SAVA best friends again
0 · Reply
zecca1889
zecca1889 Nov. 14 at 12:36 PM
$SAVA Am I wrong or am I here asking for money?
0 · Reply
TopRunners
TopRunners Nov. 14 at 11:07 AM
What is happening to ticker ARBB ?! Looks like they are going to Squeeze ticker ARBB up .. ARBB is starting to breakout! Are they pumping up ticker ARBB for 300% today!? Its insane what's going on in this market.. Looks like all eyes are going to ARBB now.. Trending #1 Watching: $NVDA $SAVA $KITT $ELAB _---
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:23 AM
Hedge Alert Live - Protect Your Portfolio Contract: $SAVA $2.50 Put · NOV 21, 2025 Exp Entry Price: $0.04 - $0.14 Exit Price Target: $0.07 Profit Margin: +69% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 14 at 5:52 AM
My only strategy since 2019 has been to buy when H% is low. Nothing else. Keep it simple and consistent. The results prove again and again why I‘ll only stick with this strategy Will trade $SAVA like how I did for others
0 · Reply
urgetosurge
urgetosurge Nov. 14 at 1:34 AM
$SAVA what a dog pile. 200 million dump cometh. It'll need a catalyst. Take the pop before the drop. https://www.otcmarkets.com/filing/html?id=18916973&guid=ytb-kpw7lRE_B3h
0 · Reply
FinABAT
FinABAT Nov. 13 at 10:04 PM
$AVXL betting against martin? You are stupid look at $SAVA and $ATYL
1 · Reply
ThaDreadPirate
ThaDreadPirate Nov. 13 at 10:04 PM
$AVXL Martin is a biotech genius. CLDN, VTL, $SAVA, $AVXL among others. All had drugs that didn’t work despite those companies convincing investprs they did. THE DATA DOESN’T LIE! Oh and if you don’t recognize those first two tickers, it’s because they don’t exist anymore.
1 · Reply